At their meeting yesterday, the members of Charité 3R elected their new speaker council. The task of the Spokesperson's Council is, among other things, the planning and coordination of the content-related and structural development of Charité 3R as well as the active promotion of networking in the Berlin research landscape. The general meeting was welcomed by Dean Prof. Axel Radlach Pries, who thanked the previous Spokesperson's Council and the Charité 3R team for their work so far.
With the help of a certified online voting tool, the members elected Prof. Stefan Hippenstiel, Prof. Andreas Hocke, Prof. Andreas Meisel, Dr. Katarina Riesner and Prof. Andreas Thiel to the Charité 3R Board of Spokespersons. Katarina Riesner represents young scientists on the Board of Spokespersons. Another member is Dr. André Dülsner, who, as Chairman of the Animal Protection Committee, belongs to the Board of Spokespersons by virtue of his office and therefore did not have to be elected.
Dr. Annemarie Lang, who has supported the Spokesperson's Council with great commitment over the past three years as a junior scientist, did not stand for re-election. The Board of Spokespersons and the entire Charité 3R team sincerely thanked Annemarie Lang for her active collaboration and is pleased that she will continue to support Charité 3R as a lecturer at the ReThink 3R workshops.
Stefan Hippenstiel, who was confirmed in office as spokesperson of Charité 3R, is head of the Molecular Infectiology and Pneumology working group at the Department of Medicine with a focus on infectiology and pneumology. He has many years of expertise in the field of 3R research and is also spokesperson for the new Berlin Einstein Center 3R. Andreas Hocke, head of the Molecular Imaging of Immunoregulation group at the Department of Medicine with focus on Infectiology and Pneumology and coordinator of the Germany-wide research network "Organo-Strat", which is funded by the German Federal Ministry of Education and Research as part of the "National Research Network of University Medicine on COVID-19". Andreas Meisel is Scientific Director of the Center for Stroke Research Berlin and Head of the Clinical Neuroscience Group at the Department of Neurology with Experimental Neurology as well as Chairman of the Berlin Stroke Alliance e.V. Katarina Riesner is PostDoc in the Experimental Stem Cell Transplantation Group at the Department of Medicine with a focus on Hematology, Oncology and Tumor Immunology and founding member of the currently emerging Refinement Taskforce for the Improvement of Practical Performances in Experimental Animals. Andreas Thiel is head of the Regenerative Immunology and Aging Unit at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) and coordinator of the currently emerging research building "The Simulated Human" (Si-M), a joint project of Charité and Technische Universität Berlin.
At the end of the meeting, Stefan Hippenstiel thanked all members for the trust they had placed in the Board of Spokespersons and emphasized: "All members of the Board of Spokespersons contribute very different and sometimes quite controversial perspectives through their different expertise, so that we represent a broad spectrum of 3R expertise within this body. We want to use this and further strengthen 3Rs in research and teaching within Charité in the coming years and advance them in the spirit of the Charité Strategy 2030."
Back to Overview